Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Sickle Cell Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sickle Cell Disease Therapeuticsmarket, defines the market attractiveness level of Sickle Cell Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sickle Cell Disease Therapeutics industry, describes the types of Sickle Cell Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sickle Cell Disease Therapeutics market and the development prospects and opportunities of Sickle Cell Disease Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sickle Cell Disease Therapeutics market in Chapter 13.
By Player:
AstraZeneca
Alnylam Pharmaceuticals
Sangamo Therapeutics
Baxter
Arena Pharmaceuticals
Blood Therapeutics
Acceleron Pharma
Bluebird bio
Pfizer
Eli Lilly
Emmaus Life Sciences
Novartis
By Type:
Sickle Cell Anemia
Sickle Beta Thalassemia
Sickle Hemoglobin C Disease
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sickle Cell Disease Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sickle Cell Disease Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sickle Cell Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sickle Cell Disease Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sickle Cell Disease Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Sickle Cell Disease Therapeutics Consumption (2017-2022)
-
7.2 United States Sickle Cell Disease Therapeutics Consumption (2017-2022)
-
7.3 Europe Sickle Cell Disease Therapeutics Consumption (2017-2022)
-
7.4 China Sickle Cell Disease Therapeutics Consumption (2017-2022)
-
7.5 Japan Sickle Cell Disease Therapeutics Consumption (2017-2022)
-
7.6 India Sickle Cell Disease Therapeutics Consumption (2017-2022)
-
7.7 South Korea Sickle Cell Disease Therapeutics Consumption (2017-2022)
8 Region and Country-wise Sickle Cell Disease Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Sickle Cell Disease Therapeutics Consumption Forecast (2022-2028)
9 Global Sickle Cell Disease Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Sickle Cell Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sickle Cell Anemia Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sickle Beta Thalassemia Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Sickle Hemoglobin C Disease Consumption and Growth Rate (2017-2022)
-
9.2 Global Sickle Cell Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Sickle Cell Disease Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Sickle Cell Anemia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sickle Beta Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Sickle Hemoglobin C Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Sickle Cell Disease Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sickle Cell Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sickle Cell Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sickle Cell Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sickle Cell Disease Therapeutics Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Sickle Cell Disease Therapeutics Product and Service
-
14.2 Alnylam Pharmaceuticals
-
14.2.1 Alnylam Pharmaceuticals Company Details
-
14.2.2 Alnylam Pharmaceuticals Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alnylam Pharmaceuticals Sickle Cell Disease Therapeutics Product and Service
-
14.3 Sangamo Therapeutics
-
14.3.1 Sangamo Therapeutics Company Details
-
14.3.2 Sangamo Therapeutics Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sangamo Therapeutics Sickle Cell Disease Therapeutics Product and Service
-
14.4 Baxter
-
14.4.1 Baxter Company Details
-
14.4.2 Baxter Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Baxter Sickle Cell Disease Therapeutics Product and Service
-
14.5 Arena Pharmaceuticals
-
14.5.1 Arena Pharmaceuticals Company Details
-
14.5.2 Arena Pharmaceuticals Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Arena Pharmaceuticals Sickle Cell Disease Therapeutics Product and Service
-
14.6 Blood Therapeutics
-
14.6.1 Blood Therapeutics Company Details
-
14.6.2 Blood Therapeutics Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Blood Therapeutics Sickle Cell Disease Therapeutics Product and Service
-
14.7 Acceleron Pharma
-
14.7.1 Acceleron Pharma Company Details
-
14.7.2 Acceleron Pharma Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Acceleron Pharma Sickle Cell Disease Therapeutics Product and Service
-
14.8 Bluebird bio
-
14.8.1 Bluebird bio Company Details
-
14.8.2 Bluebird bio Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bluebird bio Sickle Cell Disease Therapeutics Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Sickle Cell Disease Therapeutics Product and Service
-
14.10 Eli Lilly
-
14.10.1 Eli Lilly Company Details
-
14.10.2 Eli Lilly Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Eli Lilly Sickle Cell Disease Therapeutics Product and Service
-
14.11 Emmaus Life Sciences
-
14.11.1 Emmaus Life Sciences Company Details
-
14.11.2 Emmaus Life Sciences Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Emmaus Life Sciences Sickle Cell Disease Therapeutics Product and Service
-
14.12 Novartis
-
14.12.1 Novartis Company Details
-
14.12.2 Novartis Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novartis Sickle Cell Disease Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sickle Cell Disease Therapeutics
-
Figure Sickle Cell Disease Therapeutics Picture
-
Table Global Sickle Cell Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sickle Cell Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sickle Cell Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sickle Cell Disease Therapeutics Consumption by Country (2017-2022)
-
Figure United States Sickle Cell Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Sickle Cell Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Sickle Cell Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Sickle Cell Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Sickle Cell Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sickle Cell Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Cell Disease Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sickle Cell Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sickle Cell Anemia Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Beta Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Hemoglobin C Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Cell Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sickle Beta Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sickle Hemoglobin C Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sickle Cell Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sickle Cell Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Sickle Cell Disease Therapeutics Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Sickle Cell Disease Therapeutics Product and Service
-
Table Sangamo Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sangamo Therapeutics Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics Sickle Cell Disease Therapeutics Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Sickle Cell Disease Therapeutics Product and Service
-
Table Arena Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arena Pharmaceuticals Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arena Pharmaceuticals Sickle Cell Disease Therapeutics Product and Service
-
Table Blood Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Blood Therapeutics Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Blood Therapeutics Sickle Cell Disease Therapeutics Product and Service
-
Table Acceleron Pharma (Foundation Year, Company Profile and etc.)
-
Table Acceleron Pharma Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acceleron Pharma Sickle Cell Disease Therapeutics Product and Service
-
Table Bluebird bio (Foundation Year, Company Profile and etc.)
-
Table Bluebird bio Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird bio Sickle Cell Disease Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Sickle Cell Disease Therapeutics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Sickle Cell Disease Therapeutics Product and Service
-
Table Emmaus Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Emmaus Life Sciences Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Life Sciences Sickle Cell Disease Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Sickle Cell Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Sickle Cell Disease Therapeutics Product and Service
-
